Interventional Cardiology Devices | Market Insights | Japan | 2022
Although an aging population and the growing prevalence of complex lesions requiring niche devices, such as intravascular imaging catheters and CTO devices will support the Japanese IC device market, revenues will be hindered by eroding ASPs due to biennial reimbursement cuts by the MHLW over the forecast period, particularly in the mature PTCA balloon catheter and coronary stent segments, resulting in overall market contraction over the forecast period. Furthermore, the COVID-19 global pandemic will negatively impact the Japanese IC device market in the short term, hampering procedure volumes and market revenues.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for IC devices in Japan across an 11-year period.
